Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.03 – $0.55
0% from low
Exchange
OTC Link
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $192.5K | $264.2K | $207.9K | $109.5K | $69.2K | $37.0K |
| Cost of revenue | $0 | $0 | $96.5K | $155.2K | $112.8K | $58.6K | $35.2K | $68.1K |
| Gross profit | $0 | $0 | $95.9K | $109.0K | $95.0K | $50.9K | $34.0K | −$31.2K |
| Gross margin | — | — | 49.8% | 41.2% | 45.7% | 46.5% | 49.1% | -84.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$900 | −$20.8K | −$11.3K | $2.9K | $3.3K | −$119.5K | −$49.5K | −$87.2K |
| EBITDA | −$900 | $2.9K | $0 | $2.9K | $3.3K | −$91.9K | −$28.8K | −$80.8K |
| Net income | −$900 | −$17.9K | −$12.8K | $2.6K | $3.3K | −$121.8K | −$48.6K | −$87.2K |
| Net margin | — | — | -6.6% | 1.0% | 1.6% | -111.2% | -70.2% | -236.0% |
| EPS (diluted) | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
HI-GREAT GROUP HLDG CO
No one on the platform currently holds HIGR.
No tracked institution reports a position in HIGR as of their last filing.
No one on the platform has traded HIGR yet.
| $14M |
| — |
| INBPIntegrated BioPharma, Inc. | $0.18 | +0.00% | $6M | — |
| INDFYIndofood Agri Resources Ltd. | $14.25 | +0.00% | $398M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 39.1× sales vs its 481.1× historical median P/S.
Fair value ≈ $0.33 · price $0.03 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.